D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PHAS holding history
PhaseBio Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAS overviewAll 13F holders of PHASFull Q2 2026 holdings
- Shares (Q1 2022)
- 0
- Sold out in Q1 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2022 | 0 | $0 | 0.0% | −11,796−100.0% | Sold out | Holders |
| Q4 2021 | 11,796 | $31.0K | <0.1% | −66,751−85.0% | Reduced | Holders |
| Q3 2021 | 78,547 | $244.0K | <0.1% | +60,873+344.4% | Added | Holders |
| Q2 2021 | 17,674 | $66.0K | <0.1% | +17,674 | New | Holders |